Ranch Capital Advisors’s GSK GSK Stock Holding History

Ranch Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,266	Closed	-$60K	–	319
2021 Q3	$60K	Buy	+1,266	New	+$63.6K	0.04%	248
2021 Q2	–	Sell	-1,266	Closed	-$60.8K	–	275
2021 Q1	$56K	Sell	1,266 -400	-24%	-$18.2K	0.04%	272
2020 Q4	$76K	Sell	1,666 -11,815	-88%	-$543K	0.05%	241
2020 Q3	$634K	Buy	13,481 +79	+0.6%	+$3.96K	0.51%	58
2020 Q2	$685K	Buy	13,402 +1,264	+10%	+$64.8K	0.54%	49
2020 Q1	$574K	Buy	12,138 +2,050	+20%	+$109K	0.57%	47
2019 Q4	$593K	Buy	10,088 +1,882	+23%	+$105K	0.48%	56
2019 Q3	$438K	Buy	+8,206	New	+$422K	0.47%	75

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Ranch Capital Advisors's GSK Position: Q4 2021 in Review

Ranch Capital Advisors sold out of GSK (GSK) in Q4 2021, closing a stake of 1,266 shares — an estimated $60K sold.

Ranch Capital Advisors first reported a position in GSK in Q3 2019 and held it in 8 quarters. The position peaked at $685K in Q2 2020. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

Ranch Capital Advisors reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
Ranch Capital Advisors sold 1,266 GSK shares in Q4 2021, an estimated $60K.
Ranch Capital Advisors first reported a position in GSK in Q3 2019 and held it in 8 quarters.
Ranch Capital Advisors's GSK position peaked at $685K in Q2 2020.
919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Ranch Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.